COc1ccc(C[C@@H]2c3cc(O)c(OC)cc3CCN2C)cc1O.[O-][Cl+3]([O-])([O-])O
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?